Methods and compositions for inhibition of immune responses and autoimmunity
US9476053B2 · kind B2 · utility
0Cited by
25References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2015 |
| Grant date | Oct 25, 2016 |
| Priority date | — |
| Expiry date | Feb 3, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/345
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application relates to the use of immunoregulatory polynucleotides and/or immunoregulatory compounds in combination with other therapeutic agents. The application further relates to immunoregulatory polynucleotides and/or immunoregulatory compounds comprising a modified immunoregulatory sequence. It also relates to the administration of the immunoregulatory polynucleotides and/or immunoregulatory compounds comprising a modified immunoregulatory sequence to regulate an immune response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.